## Author Contributions {.page_break_before}

SL conceptualised and developed the platform and wrote the manuscript.
SF integrated BioChatter continuous integration pipelines and developed both front-end and back-end components for the BioChatter Next server.
The BioChatter consortium members contributed to the development of the platform and provided feedback on the manuscript.
AM implemented the local deployment functionality.
CW architected the BioChatter Next server infrastructure.
JB provided guidance and supervision as well as hardware resources for local LLM use and contributed to performance benchmarking.
NK implemented benchmarking procedures.
QM oversaw the development and deployment of the BioChatter Next server environment.
JSR supervised the project, revised the manuscript, and acquired funding.
All authors read and approved the final manuscript.

## Acknowledgements

We thank Hanna Schumacher, Daniel Dimitrov, Pau Badia i Mompel, and Aurelien Dugourd for feedback on the original draft of the manuscript and the software.

This work was supported by funding from the European Unionâ€™s Horizon 2020 research and innovation programme under grant agreement No 965193 (SL), award U54-AG075931 (QM) from the National Institutes of Health, award NSF1945971 (QM) from the National Science Foundation, and the Pelotonia Institute of Immuno-Oncology (PIIO).

## Disclaimer

This project is funded by the European Union under grant agreement No. 101057619.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA).
Neither the European Union nor the granting authority can be held responsible for them.
This work was also partly supported by the Swiss State Secretariat for Education, Research and Innovation (SERI) under contract No. 22.00115.

## Conflict of Interest

JSR reports funding from GSK, Pfizer and Sanofi and fees/honoraria from Travere Therapeutics, Stadapharm, Pfizer, Grunenthal, Owkin, and Astex Pharmaceuticals.

## References {.page_break_before}

<!-- Explicitly insert bibliography here -->
<div id="refs"></div>
